|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Peng Z, Liu C and Wu M: New insights into
long noncoding RNAs and their roles in glioma. Mol Cancer.
17(61)2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Anjum K, Shagufta BI, Abbas SQ, Patel S,
Khan I, Shah SAA, Akhter N and Hassan SSU: Current status and
future therapeutic perspectives of glioblastoma multiforme (GBM)
therapy: A review. Biomed Pharmacother. 92:681–689. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zhou K, Zhang C, Yao H, Zhang X, Zhou Y,
Che Y and Huang Y: Knockdown of long non-coding RNA NEAT1 inhibits
glioma cell migration and invasion via modulation of SOX2 targeted
by miR-132. Mol Cancer. 17(105)2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Smolle MA and Pichler M: The role of long
non-coding RNAs in osteosarcoma. Noncoding RNA. 4(7)2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Xu S, Kong D, Chen Q, Ping Y and Pang D:
Oncogenic long noncoding RNA landscape in breast cancer. Mol
Cancer. 16(129)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhang CJ, Liu C, Wang YX, Zhu N, Hu ZY,
Liao DF and Qin L: Long non-coding RNA-SRA promotes neointimal
hyperplasia and vascular smooth muscle cells proliferation via
MEK-ERK-CREB pathway. Vascul Pharmacol. 116:16–23. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
He D, Zeng H, Chen J, Xiao L, Zhao Y and
Liu N: H19 regulates trophoblastic spheroid adhesion by
competitively binding to let-7. Reproduction. 157:423–430.
2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ma Z: Downregulation of SETD8 by miR-382
is involved in glioma progression. Pathol Res Pract. 214:356–360.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Bo H, Fan L, Gong Z, Liu Z, Shi L, Guo C,
Li X, Liao Q, Zhang W, Zhou M, et al: Upregulation and
hypomethylation of lncRNA AFAP1AS1 predicts a poor prognosis and
promotes the migration and invasion of cervical cancer. Oncol Rep.
41:2431–2439. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Jiang H, Xiong W, Chen L, Lv Z, Yang C and
Li Y: Knockdown of the long noncoding RNA HOTTIP inhibits cell
proliferation and enhances cell sensitivity to cisplatin by
suppressing the Wnt/β-catenin pathway in prostate cancer. J Cell
Biochem. 120:8965–8974. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhou S, Yu L, Xiong M and Dai G: lncRNA
SNHG12 promotes tumorigenesis and metastasis in osteosarcoma by
upregulating Notch2 by sponging miR-195-5p. Biochem Biophys Res
Commun. 495:1822–1832. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tan P, Guo YH, Zhan JK, Long LM, Xu ML, Ye
L, Ma XY, Cui XJ and Wang HQ: lncRNA-ANRIL inhibits cell senescence
of vascular smooth muscle cells by regulating miR-181a/Sirt1.
Biochem Cell Biol. 97:571–580. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Lin C, Zhang Y, Chen Y and Bai Y: Long
noncoding RNA LINC01234 promotes serine hydroxymethyltransferase 2
expression and proliferation by competitively binding miR-642a-5p
in colon cancer. Cell Death Dis. 10(137)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Fu X, Zhu X, Qin F, Zhang Y, Lin J, Ding
Y, Yang Z, Shang Y, Wang L, Zhang Q and Gao Q: Linc00210 drives
Wnt/β-catenin signaling activation and liver tumor progression
through CTNNBIP1-dependent manner. Mol Cancer.
17(73)2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297.
2004.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Tan Z, Zhao J and Jiang Y: miR-634
sensitizes glioma cells to temozolomide by targeting CYR61 through
Raf-ERK signaling pathway. Cancer Med. 7:913–921. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Xiao F, Li Y, Wan Y and Xue M:
MircroRNA-139 sensitizes ovarian cancer cell to cisplatin-based
chemotherapy through regulation of ATP7A/B. Cancer Chemother
Pharmacol. 81:935–947. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhu Y, Zhao H, Rao M and Xu S:
MicroRNA-365 inhibits proliferation, migration and invasion of
glioma by targeting PIK3R3. Oncol Rep. 37:2185–2192.
2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhang J, Gong X, Tian K, Chen D, Sun J,
Wang G and Guo M: miR-25 promotes glioma cell proliferation by
targeting CDKN1C. Biomed Pharmacother. 71:7–14. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wu Z, Sun L, Wang H, Yao J, Jiang C, Xu W
and Yang Z: miR-328 expression is decreased in high-grade gliomas
and is associated with worse survival in primary glioblastoma. PLoS
One. 7(e47270)2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yuan J, Zheng Z, Zheng Y, Lu X, Xu L and
Lin L: microRNA-328 is a favorable prognostic marker in human
glioma via suppressing invasive and proliferative phenotypes of
malignant cells. Int J Neurosci. 126:145–153. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang Y, Wang M, Wei W, Han D, Chen X, Hu
Q, Yu T, Liu N, You Y and Zhang J: Disruption of the
EZH2/miRNA/β-catenin signaling suppresses aerobic glycolysis in
glioma. Oncotarget. 7:49450–49458. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zhang S, Li P, Zhao L and Xu L: LINC00210
as a miR-328-5p sponge promotes nasopharyngeal carcinoma
tumorigenesis by activating NOTCH3 pathway. Biosci Rep.
38(BSR20181168)2018.PubMed/NCBI View Article : Google Scholar
|
